Payne, A. B., Watts, J. A., Mitchell, P. K., Dascomb, K., Irving, S. A., Klein, N. P., Grannis, S. J., Ong, T. C., Ball, S. W., DeSilva, M. B., Natarajan, K., Sheffield, T., Bride, D., Arndorfer, J., Naleway, A. L., Koppolu, P., Fireman, B., Zerbo, O., Timbol, J., … Link-Gelles, R. (2024). Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. The Lancet, 404(10462), 1547–1559. https://doi.org/10.1016/s0140-6736(24)01738-0
Publication Date
Columbia Affiliation